Fresenius Medical Care AG (FMS) Operating Leases (2018 - 2026)

Fresenius Medical Care AG's Operating Leases history runs 9 years deep, the most recent figure standing at $19.2 million for Q1 2026.

• In Q1 2026, Operating Leases fell 28.07% year-over-year to $19.2 million; the TTM figure through Mar 2026 stood at $19.2 million (down 28.07% YoY), while the FY2025 annual figure was $21.1 million, down 99.82% from the prior year.
• Operating Leases for Q1 2026 stood at $19.2 million, down from $21.1 million in the prior quarter.
• The five-year high for Operating Leases was $15.0 billion in Q1 2022, with the low at $19.2 million in Q1 2026.
• The 5-year median for Operating Leases is $29.1 million (2025), against an average of $4.7 billion.
• The sharpest annual moves came in 2023 and 2024: Operating Leases sank 99.82% in 2023, then jumped 49485.76% in 2024.
• Fresenius Medical Care AG's Operating Leases stood at $156.8 million in 2022, then surged by 8261.75% to $13.1 billion in 2023, then dropped by 10.45% to $11.7 billion in 2024, then slumped by 99.82% to $21.1 million in 2025, then slipped by 8.96% to $19.2 million in 2026.
• Business Quant data shows FMS's Operating Leases at $19.2 million in Q1 2026, $21.1 million in Q4 2025, and $30.2 million in Q3 2025.